
Unimedia Pharmaceuticals Private Limited
This company manufactures pharmaceutical, medicinal, chemical, and botanical products in various forms.
This company manufactures pharmaceutical, medicinal, chemical, and botanical products in various forms.
Unimedia Pharmaceuticals Private Limited (UPPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 March 2013 and has a history of 12 years and two months. Its registered office is in Ahmedabad, Gujarat, India.
The Corporate was formerly known as Aqsa Remedies Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹6.06 M.
Mohammadzahid Mall and Abdulrashid Mall serve as directors at the Company.
Ahmedabad, Gujarat, India
+91-XXXXXXXXXX
U24233GJ2013PTC074110
074110
Private Limited Indian Non-Government Company
21 Mar 2013
30 Sep 2024
31 Mar 2024
Unlisted
Roc Ahmedabad
Unimedia Pharmaceuticals Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Antacid Drugs, Pain Relief Drugs & Pharmaceuticals, Diclofenac, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Common Disease Medicines, Antihistamines, Third Party Manufacturing Consultancy, Pharmaceutical Contract Manufacturing Services.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mohammadzahid Mall ![]() | Director | 21-Mar-2013 | Current |
Abdulrashid Mall ![]() | Director | 21-Mar-2013 | Current |
Unimedia Pharmaceuticals Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 5.49% increase. The company also saw a substantial improvement in profitability, with a 134.63% increase in profit. The company's net worth Soared by an impressive increase of 17.18%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
Unlock access to Unimedia Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
₹6.06 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
07 Nov 2023 | Others | ₹0.93 M | Open |
15 Nov 2019 | Others | ₹0.90 M | Open |
18 Nov 2013 | Others | ₹4.23 M | Open |
Unlock and access historical data on people associated with Unimedia Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Unimedia Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unimedia Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Unimedia Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Unimedia Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
A charge with Others amounted to Rs. 0.93 M with Charge ID 100836944 was registered on 07 Nov 2023.
A charge with Others of Rs. 4.23 M registered on 18 Nov 2013 with Charge ID 10466940 was modified on 14 Jul 2020.
A charge with Others amounted to Rs. 0.90 M with Charge ID 100320020 was registered on 15 Nov 2019.
A charge with Others amounted to Rs. 4.23 M with Charge ID 10466940 was registered on 18 Nov 2013.
Unimedia Pharmaceuticals Private Limited was incorporated on 21 Mar 2013.
The authorized share capital of Unimedia Pharmaceuticals Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.50 M.
Currently 2 directors are associated with Unimedia Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Unimedia Pharmaceuticals Private Limited is Plot 1706 Phase Iii, Gidc Vatva India, Ahmedabad, Gujarat, 382445.
The corporate identification number (CIN) of Unimedia Pharmaceuticals Private Limited is U24233GJ2013PTC074110 and the company number is 074110 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2024, the revenue trend for Unimedia Pharmaceuticals Private Limited has risen by 5.49%.
The financial reports for the fiscal year 2024 indicates that The net worth of Unimedia Pharmaceuticals Private Limited has experienced an upsurge of 17.18%.
As per the financial statements for fiscal Year 2024, The total open charges for Unimedia Pharmaceuticals Private Limited amount to ₹ 6.06 M.
The most recent Balance Sheet for Unimedia Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.